Literature DB >> 17628600

Protective effects of melatonin and N-acetylcysteine on hepatic injury in a rat cardiopulmonary bypass model.

Hairong Huang1, Rong Yin, Jiaquan Zhu, Xiaomei Feng, Changtian Wang, Yi Sheng, Guohua Dong, Demin Li, Hua Jing.   

Abstract

BACKGROUND: An increasing number of patients were undergoing cardiac surgery with cardiopulmonary bypass (CPB) and more attention had been paid to hepatic injury after CPB. This study was designed to test the hypothesis that melatonin and N-acetylcysteine (NAC) could attenuate hepatic injury induced by CPB in rats.
MATERIALS AND METHODS: Male Sprague Dawley rats were randomly divided into four groups: sham, control (CPB + placebo), NAC (CPB + 250 mg/kg N-acetylcysteine), and melatonin (CPB + 20 mg/kg melatonin). Blood samples were collected at the beginning, at the end of CPB, and at 0.5, 1, 2, 3, and 24 h postoperation. Liver samples were harvested at 24 h after the operation.
RESULTS: In the control group, the levels of serum liver enzymes and tumor necrosis factor-alpha, activities of inducible nitric oxide synthase, malondialdehyde, and myeloperoxidase in liver tissue were significantly increased. In addition, swollen hepatocytes, vacuolization, and congestion in sinusoids were observed. These changes were markedly reversed in both NAC and melatonin groups. Furthermore, the glutathione content and liver antioxidative enzymes activities were significantly decreased in the control group compared with the sham group. However, the levels of these antioxidants were markedly elevated after NAC or melatonin treatment compared with placebo treatment.
CONCLUSIONS: Our findings showed that NAC and melatonin had acceptably beneficial effects against the CPB-induced hepatic injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628600     DOI: 10.1016/j.jss.2006.12.553

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Cardiopulmonary bypass model in the rat: a new minimal invasive model with a low flow volume.

Authors:  Guillaume Lebreton; Fabienne Tamion; Jean-Paul Bessou; Fabien Doguet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17

2.  Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients.

Authors:  M Diab; C Sponholz; C von Loeffelholz; P Scheffel; M Bauer; A Kortgen; T Lehmann; G Färber; M W Pletz; T Doenst
Journal:  Infection       Date:  2017-08-30       Impact factor: 3.553

3.  N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease.

Authors:  Manouchehr Khoshbaten; Akbar Aliasgarzadeh; Koorosh Masnadi; Mohammad K Tarzamani; Sara Farhang; Hosain Babaei; Javad Kiani; Maryam Zaare; Farzad Najafipoor
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

Review 4.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.